Cancer
Weill Family Foundation Donates $50 Million to Launch the Weill Cancer Hub East
A groundbreaking initiative, the Weill Cancer Hub East, has emerged from a $50 million donation from the Weill Family Foundation,...
Singaporean Researchers Create Tumor Maps to Enhance Precision Treatment for Stomach Cancer
In a groundbreaking study, researchers in Singapore have made monumental strides in understanding gastric cancer, a condition that remains one...
Leveraging Inherited Cancer Risk for Tailored Therapeutic Approaches
Mutations in the BRCA2 gene have long been implicated in a variety of cancers, including breast, ovarian, prostate, and pancreatic...
Compact Rolling Robot Performs Virtual Biopsies
A groundbreaking advancement in medical technology has emerged from the University of Leeds, where researchers have developed a tiny magnetic...
Breakthrough Research from UT Health San Antonio Offers New Hope in Slowing or Preventing Glioblastoma Recurrence
In a groundbreaking discovery that could change the landscape of glioblastoma treatment, researchers at The University of Texas Health Science...
March 26, 2025: Key Advances in MSK Research Unveiled
New research emerging from Memorial Sloan Kettering Cancer Center (MSK) reveals groundbreaking advancements in understanding mitochondrial DNA deletions, the mechanisms...
New Study Reveals Connection Between Light Physical Activity and Reduced Cancer Risk
In a groundbreaking prospective cohort study involving over 85,000 adults across the United Kingdom, researchers from the National Institutes of...
THz Waves: A Promising Target for Cancer Treatment in Living Cells
Since the inception of research into terahertz (THz) radiation, scientists have been captivated by its potential to transform various fields,...
FDA Grants Approval for Innovative Dual-Action Therapy Targeting Previously Treated Advanced Neuroendocrine Tumors, Supported by Dana-Farber Research
Cabozantinib, an innovative oral tyrosine kinase inhibitor, has recently received approval from the U.S. Food and Drug Administration (FDA) for...
Newly Identified Mechanism: Glutamate Sparks Rapid Liver Regeneration
Researchers at the National Cancer Research Centre (CNIO) have unveiled a groundbreaking discovery concerning liver regeneration mechanisms in mice, as...
New Insights Reveal Complexities in Cellular Responses to Stress
Cleveland has recently emerged as a focal point in the study of cellular stress responses, especially within the framework of...
Examining the Effects of the Pandemic on Colorectal Cancer Screening and Diagnosis: Insights from Two Key Studies
The COVID-19 pandemic has had profound implications for healthcare systems worldwide, particularly in the domain of cancer prevention and diagnosis....
Revolutionizing Antibody Engineering with Innovative Fusion Protein Technology
The Food and Drug Administration (FDA) has taken a significant step in the advancement of therapeutic interventions by approving over...
Unlocking Regeneration: CU Cancer Center Researchers Discover Key Mechanism Behind Intestinal Cell Recovery After Injury
Researchers at the University of Colorado Cancer Center have unveiled a significant breakthrough in understanding the cellular mechanisms that could...
Lupus-Associated Antibody Demonstrates Potential to Boost Cancer Treatment Effectiveness
Yale researchers have uncovered a groundbreaking approach to elicit immune responses against previously neglected tumors, utilizing a notable antibody that...
Unequal Access to MRI: A Barrier in Prostate Cancer Detection
Prostate cancer remains a significant public health issue, accounting for the second-highest number of cancer-related deaths in American men. The...
Understanding Why Certain Breast Cancer Therapies Lose Effectiveness
Breast cancer remains a significant global health challenge, impacting millions of women across different cultures and demographics. Recent findings from...
Research Team Unveils Groundbreaking Global Cooperative Interactions Among Cervical Cancer Cells
In a groundbreaking study published in Scientific Reports, a team of researchers from YOKOHAMA National University has unveiled a novel...
ACS Study Reveals Tobacco Control Efforts Averted Nearly Four Million Premature Lung Cancer Deaths in the U.S., Resulting in 76 Million Years of Life Saved
New research published in the renowned journal "CA: A Cancer Journal for Clinicians" offers compelling insights into the significant advancements...
City of Hope Launches Phase 1 Clinical Trial to Transform Rectal Cancer Treatment with Radiation Therapy, Minimizing Surgical Side Effects
In a groundbreaking development in the field of oncology, City of Hope, one of the foremost cancer research and treatment...
